Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jennifer Baker-Malcolm"'
Autor:
Huawei Qiu, Xiaoying Jin, Debra A. Barngrover, Karen Lee, Laura Geagan, Tim Edmunds, Lorraine Copertino, Laura Andrews, Kate Zhang, Keirsten Seiger, John M. McPherson, Jennifer Baker-Malcolm
Publikováno v:
Glycobiology. 13:305-313
Fabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme (agalsidase beta) and Replagal (agalsidase alfa), have been approved in Europe as enzyme replace
Autor:
Huawei Qiu, Tim Edmunds, Heather Hughes, Scott Estes, Kenneth P. Karey, Cordula Schwarz, Jennifer Baker-Malcolm, Scott M. Van Patten
Publikováno v:
The Journal of biological chemistry. 278(35)
One form of Niemann-Pick disease is caused by a deficiency in the enzymatic activity of acid sphingomyelinase. During efforts to develop an enzyme replacement therapy based on a recombinant form of human acid sphingomyelinase (rhASM), purified prepar
Autor:
D. Barngrover, K. Lee, J.M. McPherson, X. Jin, T. Edmunds, K. Zhang, L. Copertino, L. Andrews, J. Baker-Malcolm, L. Geagan, H. Qiu, K. Seiger
Publikováno v:
Glycobiology; Apr2003, Vol. 13 Issue 4, p305-313, 9p
Autor:
Scott M. Van Patten, Heather Hughes, Michael R. Huff, Peter A. Piepenhagen, James Waire, Huawei Qiu, Chandrashekar Ganesa, David Reczek, Paul V. Ward, Joseph P. Kutzko, Tim Edmunds
Publikováno v:
Glycobiology; May2007, Vol. 17 Issue 5, p467-467, 1p
Autor:
Barry M. McGrath, Gary Walsh
Carefully crafted to provide tightly focused and authoritative information, the Directory of Therapeutic Enzymes covers all approved therapeutic enzymes currently used in medicine. Written mainly by industry experts, the book includes information sou